Alnylam Pharmaceuticals, Inc.
Time frame: 1 May 2023 - 30 April 2024Article ‘Count’ and ‘Share’ for Alnylam Pharmaceuticals, Inc. based on listed parameters only.
The articles listed below published by authors from Alnylam Pharmaceuticals, Inc., organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
Journal | Count | Share |
---|---|---|
JAMA: The Journal of the American Medical Association |
1 | 0.55 |
Journal of Biological Chemistry |
1 | 0.44 |
Journal of Hepatology |
1 | 0.16 |
Journal of the American Chemical Society |
1 | 0.81 |
Nature |
1 | 0.07 |
Nature Chemical Biology |
1 | 0.05 |
PLOS Genetics |
1 | 0.14 |
The New England Journal of Medicine |
2 | 0.76 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.